|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | CXCR4 neutralization,a novel therapeutic approach for non-hodgkinps lymphoma显示文摘 | Bertolini F Agnola CD Mancuso P | 2002 | Cancer Res2002，62，： | 1 |
| 2 | Social cognition in psy- chosis: Multidimensional structure, clinical correlates and rela- tionship with functional outcome显示文摘 | Mancuso F Horan W P Kern R S | 2011 | Schizophr Res2011，125，23： | 1 |
| 3 | The thin red line: Angiogenesis in normal and malignant hematopoiesis 显示文摘 | Bertolini F Mancuso P Gobbi A | 2000 | Exp henmatol2000，28，9： | 1 |
| 4 | Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endo- thelial progenitor cells显示文摘 | Bertolini F Paul S Mancuso P | 2003 | Cancer Res2003，63，15： | 1 |
| 5 | A Genetic Algorithm for Combined Topology and Shape Optimisations显示文摘 | CAPPLLO F MANCUSO A | 2003 | Computer-Aided Design2003，，35： | 1 |
| 6 | The thin red line:Angiogenesis in normal and malignant hematopoiesis显示文摘 | Bertolini F Mancuso P Gobbi A | 2000 | Exp hematol2000，28，9： | 1 |
| 7 | Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells显示文摘 | Bertolini F Paul S Mancuso P | 2003 | Cancer Res2003，63，15： | 1 |
| 8 | Endostatin,an antigiogenic drug,induces tumor stabilization after chemotherapy or antiCd20 therapy in a NOD/SCID mouse model of huaman highgrade non-Hodgkin lymphoma显示文摘 | Bertolini F Fusetti L Mancuso P | 2000 | Blood2000，96，1： | 1 |
| 9 | Endostatin, an antiangiogenic drug, induces tumor stalization after chemotherapy or anti - CD20 therapy in a NOD/SCID mouse Model of human high - grade non - Hodgkin lymphoma 显示文摘 | Bertolini F Fusetti L Mancuso P | 2000 | Blood2000，96，1： | 1 |
| 10 | Attribution of vascular phenotypes of the murine Efg17 locus to the microRNA miRNA-126显示文摘 | Kuhnert F Mancuso MR Hampton J | | Development0，，： | 1 |
| 11 | Digital image stabilization by adaptive block motion vectors filtering显示文摘 | Vella F Oastorina A Mancuso M | 2002 | IEEE Trans on Consumer Electronics2002，48，3： | 1 |
| 12 | Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells显示文摘 | Bertolini F Paul S Mancuso P | 2003 | Cancer Res2003，63，： | 1 |
| 13 | Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker显示文摘 | MANCUSO M ORSUCCI D COPPEDt F et a! | 2009 | Curr Mol Med2009，9，9： | 1 |
| 14 | Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma 显示文摘 | Bertolini F Fusetti L Mancuso P | 2000 | Blood2000，96，1： | 1 |
| 15 | Comparing fractal analysis,electrical impedance and electrolyte leakage for the assessment of cold tolerance in CaUistemon and Grevillea spp 显示文摘 | Mancuso S Nicese F P Masi E | 2004 | J Hortic Sci Biotech2004，79，： | 1 |
| 16 | Endostatin, an antiangio genic drug,induces tumor stabilization after chemotherapy or an- ti CD20 therapy in a NOD/SCID mouse model of human high grade non-Hodgkin lymphoma显示文摘 | Bertolini F Fusetti L Mancuso P | 2000 | Blood2000，96，1： | 1 |
| 17 | Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 显示文摘 | Kuhnert F Mancuso MR Hampton J Stankunas K Asano T Chen CZ | 2008 | Development2008，135，24： | 1 |
| 18 | Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells 显示文摘 | Bertolini F Paul S Mancuso P | 2003 | Cancer Res2003，63，： | 1 |
| 19 | Calcified Parathyroid Glands Detected by Computed Tomography显示文摘 | Lineaweaver W Clare F Mancuso A | 1984 | J Comput Assist Tomogr1984，8，5： | 1 |
| 20 | Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma 显示文摘 | Bertolini F Fusetti L Mancuso P | 2000 | Blood2000，96，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员